We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+13.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$17.1B
AUM Growth
+$2.28B
Cap. Flow
+$553M
Cap. Flow %
3.24%
Top 10 Hldgs %
20.87%
Holding
2,825
New
311
Increased
1,187
Reduced
1,145
Closed
119

Sector Composition

Rank Sector Weight
1 Technology 9.45%
2 Consumer Discretionary 4.97%
3 Healthcare 4.39%
4 Financials 4.25%
5 Communication Services 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SUPV
2651
Grupo Supervielle
SUPV
$725M
$42K ﹤0.01%
20,000
-717
-3% -$1.36K
TGB
2652
Trekor Metals
TGB
$3.2B
$41K ﹤0.01%
31,350
-20,000
-39% -$21.2K
QEP
2653
DELISTED
QEP RESOURCES, INC.
QEP
$41K ﹤0.01%
17,052
-2,439
-13% -$3.61K
NERV icon
2654
Minerva Neurosciences
NERV
$187M
$40K ﹤0.01%
2,113
-325
-13% -$8.19K
DXYN
2655
DELISTED
Dixie Group Inc
DXYN
$40K ﹤0.01%
15,507
-16,500
-52% -$28K
POWW icon
2656
Outdoor Holding Co
POWW
$267M
$37K ﹤0.01%
+11,200
New +$35.9K
XXII
2657
22nd Century Group
XXII
$1.49M
0
PTE
2658
DELISTED
PolarityTE, Inc. Common Stock
PTE
$37K ﹤0.01%
2,193
-1,092
-33% -$23.1K
AHT
2659
Ashford Hospitality Trust
AHT
$19.8M
$35K ﹤0.01%
+137
New +$34.9K
GORO icon
2660
Goldgroup Mining Inc.
GORO
$211M
$35K ﹤0.01%
+11,999
New +$37.2K
CARM
2661
DELISTED
Carisma Therapeutics
CARM
$34K ﹤0.01%
1,245
NBEV
2662
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$34K ﹤0.01%
12,760
-350
-3% -$951
AUD
2663
DELISTED
Audacy, Inc.
AUD
$33K ﹤0.01%
13,185
-800
-6% -$1.63K
THM
2664
International Tower Hill Mines
THM
$733M
$32K ﹤0.01%
+22,975
New +$33.1K
NGD
2665
DELISTED
New Gold Inc
NGD
$31K ﹤0.01%
14,319
-13,200
-48% -$26.9K
CPIX icon
2666
Cumberland Pharmaceuticals
CPIX
$119M
$30K ﹤0.01%
10,000
TLPH icon
2667
Talphera
TLPH
$72.7M
$30K ﹤0.01%
1,212
+148
+14% +$4.52K
THER
2668
DELISTED
THERATECHNOLOGIES INC COM
THER
$30K ﹤0.01%
12,130
-3,603
-23% -$8.91K
CLSD
2669
DELISTED
Clearside Biomedical
CLSD
$27K ﹤0.01%
+667
New +$17.3K
AMTX icon
2670
Aemetis
AMTX
$126M
$25K ﹤0.01%
10,000
DMK
2671
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$24K ﹤0.01%
698
+29
+4% +$1.29K
UEC icon
2672
Uranium Energy
UEC
$5.62B
$23K ﹤0.01%
+13,100
New +$15.5K
OGI
2673
Organigram Holdings
OGI
$182M
$22K ﹤0.01%
4,080
-554
-12% -$2.84K
MARK
2674
DELISTED
Remark Holdings, Inc.
MARK
$22K ﹤0.01%
1,157
-64
-5% -$873
RBAC.WS
2675
DELISTED
RedBall Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordina
RBAC.WS
$22K ﹤0.01%
+10,000
New +$18K

Similar funds

Cambridge Investment Research Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, Cambridge Investment Research Advisors held 2,825 positions worth $17.1B, up 15% from $14.8B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $553M of net new capital in Q4 2020, opening 311 new positions and adding to 1,187 existing holdings. Its largest new stake was iPath Shiller CAPE ETN: 348,970 shares worth $6.21M.

By sector, the portfolio is most concentrated in Technology at 9.4% of assets, down from 9.8% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $30.8M trimmed.

  • Cambridge Investment Research Advisors's largest Q4 2020 buy was iPath Shiller CAPE ETN: 348,970 shares worth $6.21M.
  • Cambridge Investment Research Advisors added most to Vanguard Total International Stock ETF in Q4 2020, an estimated $80.9M increase.
  • Cambridge Investment Research Advisors's biggest Q4 2020 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $30.8M.
  • Cambridge Investment Research Advisors fully exited Invesco BulletShares 2020 Corporate Bond ETF in Q4 2020, selling an estimated $10.8M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $17.1B portfolio in Q4 2020.
  • Cambridge Investment Research Advisors opened 311 new positions and closed 119 in Q4 2020.
  • Cambridge Investment Research Advisors's portfolio value rose 15% quarter-over-quarter to $17.1B.

Based on Cambridge Investment Research Advisors's 13F filing for Q4 2020, filed 4 Feb 2021.